The "Panorama" program on the Belarus 1 TV channel aired a report on the development of computer modeling for pharmaceuticals. Featured are Vladimir Stepanovich Karanik, Chairman of the Presidium of the National Academy of Sciences of Belarus, and Anna Dmitrievna Karpenko, a researcher at the Laboratory of Mathematical Cybernetics at the Joint Institute for Informatics and Problems of the National Academy of Sciences of Belarus.

Scientists are using the supercomputer center's computing power to model molecules capable of diagnosing the most complex modern diseases at the earliest stages—COVID-19, tuberculosis, and cancer.

"In the case of SARS-CoV-2, we searched for compounds in large databases to find ways to repurpose them and identify effective molecules against SARS-CoV-2 that are not yet patented," said Anna Dmitrievna Karpenko. "With tuberculosis, the challenge was different—we needed to generate fundamentally new compounds that are not yet on the market and not included in patented databases."

The demand for such expertise is simple: classical pharmacology requires the assistance of modern technologies. Developing a single drug using traditional methods takes up to 15 years. The development of the Joint Institute for Informatics and Problems of the National Academy of Sciences of Belarus could significantly shorten this time. "It's clear that the clinical trials, safety and efficacy assessments—everything related to human safety—will be traditional," explains Vladimir Stepanovich Karanik.

Details in the story.